Cancer Registration: Principles and Methods

Total Page:16

File Type:pdf, Size:1020Kb

Cancer Registration: Principles and Methods WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER AND INTERNATIONAL ASSOCIATION OF CANCER REGISTRIES Cancer Registration: Principles and Methods Edited by O.M. Jensen, D.M. Parkin, R. MacLennan, C.S. Muir and R.G. Skeet IARC Scientific Publications No. 95 International Agency for Research on Cancer Lyon, France 1991 Published by the International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France 0International Agency for Research on Cancer, 1991 Distributed by Oxford University Press, Walton Street, Oxford OX2 6DP, UK Distributed in the USA by Oxford University Press, New York All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the copyright holder. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. ISBN 92 832 1195 2 ISSN 0300-5085 Printed in the United Kingdom Contents Foreword ....................................................................................................... vii Chapter 1. Introduction K. Shanmugaratnam .................................................................................... Chapter 2. History of cancer registration G. Wagner .................................................................................................. Chapter 3. Purposes and uses of cancer registration 0.M. Jensen and H.H. Storm ..................................................................... Chapter 4. Planning a cancer registry 0.M. Jensen and S. Whelan ........................................................................ Chapter 5. Data sources and reporting J. Powell ..................................................................................................... Chapter 6. Items of patient information which may be collected by registries R. MacLennan ............................................................................................ Chapter 7. Classification and coding of neoplasms C.S. Muir and C. Percy .............................................................................. Chapter 8. Manual and computerized cancer registries R.G. Skeet .................................................................................................. Chapter 9. Quality and quality control R.G. Skeet .................................................................................................. Chapter 10. Reporting of results 0.M. Jensen and H.H. Storm ..................................................................... Chapter 11. Statistical methods for registries P. BoyIe and D.M. Parkin .......................................................................... Chapter 12. Analysis of survival D.M. Parkin and T. HakuIinen ................................................................... Chapter 13. The hospital-based cancer registry J.L. Young .................................................................................................. Chapter 14. Cancer registration in developing countries D.M. Parkin and L.D. Sanghvi ................................................................... Chapter 15. Cancer registration: legal aspects and confidentiality C.S. Muir and E. Dimaret .......................................................................... vi Contents Appendix 1. United Nations Standard Country Codes ............................... Appendix 2. Editing for consistency of data items V. Van Holten ............................................................................................ Appendix 3. (a) The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection H.H. Storm ...................... .............................. .. .. ................ .... .......... (b) The Thames Cancer Registry R.G. Skeet ... .. .. .. .. .. .. .. .. ..... .. .. .. .. .. , .. (c) Cancer registration in Ontario E.A. Clarke, L.D. Marrett and N. Kreiger .... .. ... ... (d) The Department of Health-Rizal Cancer Registry A. V. Luudico and D. Esteban ............ .. ............. .. ................. ...... ........ Appendix 4. CANREG : Cancer registration software for microcomputers M.P. Coleman and C.A. Bieber .. .. .. .. , .. References .. , .. , . .. Index .. Foreword The maintenance of a register of cancer cases serves many purposes; The recording of cases diagnosed and treated in a single hospital has a primarily clinical function, and is a valuable resource for monitoring and evaluating the work of the institution concerned, including the end results achieved. Registries which record the cancer cases arising in a defined population have rather different goals, which can be broadly categorized as assisting in planning and evaluating cancer-control activities for the populations concerned, and providing a data resource for epidemiological studies of cancer causation. This volume is concerned almost entirely with the functions of such population-based cancer registries, although one chapter is devoted to outlining the specialized functions of the hospital registry. The development of population-based cancer registration, particularly over the last 20-25 years, has been marked by increasing standardization of methods and definitions. This process has been greatly facilitated by the foundation of the International Association of Cancer Registries (IACR) in 1966, and this monograph is the result of the close collaboration that has evolved between the Association and the International Agency for Research on Cancer (IARC). The first manual on cancer registration methodology was published as recently as 1976 (WHO Handbook for Standardized Cancer Registries (Hospital Based), WHO Offset Publications No. 25). Two years later IARC and IACR published Cancer Registration and Its Techniques (by MacLennan, R., Muir, C.S., Steinitz, R. & Winkler, A.; IARC Scientific Publications No. 21), which incorporated all of the material from the earlier handbook, but made additions and changes of emphasis appropriate to population- based registries. Twelve years later, much of the work of cancer registries has been revolutionized by the almost universal availability of computers. Electronic storage and processing of data has greatly enhanced the potential for quality control, and analysis of the data collected has become a routine function, rather than solely an annual event. This monograph reflects these changes, and the now obsolete technology, based on manual filing and card indexes is outlined only briefly. The monograph describes the steps involved in planning and operating a population-based registry. Several chapters are devoted to the uses to which cancer registry data may be put, and the methods appropriate for the analysis and presentation of results. Guidance is also provided on appropriate definitions and codes for the variables commonly collected by cancer registries, which includes a section on the classification and coding of neoplasms. It is thus intended that this monograph will replace its predecessors in becoming the standard work of reference on cancer registration methods. L. Tomatis D.B. Thomas Director President IARC IACR vii Chapter 1. Introduction K. Shanmugaratnam Department of Pathology, National University of Singapore, National University Hospital, Lower Kent Ridge Road, Singapore 051 1, Republic of Singapore The cancer registry has a pivotal role in cancer control. Its primary function is the maintenance of a file or register of all cancer cases occurring in a defined population in which the personal particulars of cancer patients and the clinical and pathological characteristics of the cancers, collected continuously and systematically from various data sources, are documented. The registry analyses and interprets such data periodically and provides information on the incidence and characteristics of specific cancers in various segments of the resident population and on temporal variations in incidence. Such information is the primary resource not only for epidemiological research on cancer determinants but also for planning and evaluating health services for the prevention, diagnosis and treatment of the disease. Cancer registries can also be used for monitoring occupational groups and cohorts of individuals exposed to various carcinogens and as a convenient source of subjects for clinical and epidemiological studies. Those based in hospitals have an important supportive role in the care of cancer patients by assisting clinicians in the follow-up of their cases and by providing statistical data on the results of therapy. The value of a cancer registry depends on the quality of its data and the extent to which they are used in research and health services planning. It is obviously important that the registration of cancer cases should be as complete as possible. The operation of some registries has been seriously curtailed by laws or regulations, designed to ensure secrecy of information, that prevent cross-linkage of different data files, including access to the personal identity of deceased persons in death records. In view of the enormous and rapidly increasing burden of cancer on the community,
Recommended publications
  • Most-Common-Surnames-Bmd-Registers-16.Pdf
    Most Common Surnames Surnames occurring most often in Scotland's registers of Births, Marriages and Deaths Counting only the surname of the child for births, the surnames of BOTH PARTIES (for example both BRIDE and GROOM) for marriages, and the surname of the deceased for deaths Note: the surnames from these registers may not be representative of the surnames of the population of Scotland as a whole, as (a) they include the surnames of non-residents who were born / married / died here; (b) they exclude the surnames of residents who were born / married / died elsewhere; and (c) some age-groups have very low birth, marriage and death rates; others account for most births, marriages and deaths.ths Registration Year = 2016 Position Surname Number 1 SMITH 2056 2 BROWN 1435 3 WILSON 1354 4 CAMPBELL 1147 5 STEWART 1139 6 THOMSON 1127 7 ROBERTSON 1088 8 ANDERSON 1001 9 MACDONALD 808 10 TAYLOR 782 11 SCOTT 771 12 REID 755 13 MURRAY 754 14 CLARK 734 15 WATSON 642 16 ROSS 629 17 YOUNG 608 18 MITCHELL 601 19 WALKER 589 20= MORRISON 587 20= PATERSON 587 22 GRAHAM 569 23 HAMILTON 541 24 FRASER 529 25 MARTIN 528 26 GRAY 523 27 HENDERSON 522 28 KERR 521 29 MCDONALD 520 30 FERGUSON 513 31 MILLER 511 32 CAMERON 510 33= DAVIDSON 506 33= JOHNSTON 506 35 BELL 483 36 KELLY 478 37 DUNCAN 473 38 HUNTER 450 39 SIMPSON 438 40 MACLEOD 435 41 MACKENZIE 434 42 ALLAN 432 43 GRANT 429 44 WALLACE 401 45 BLACK 399 © Crown Copyright 2017 46 RUSSELL 394 47 JONES 392 48 MACKAY 372 49= MARSHALL 370 49= SUTHERLAND 370 51 WRIGHT 357 52 GIBSON 356 53 BURNS 353 54= KENNEDY 347
    [Show full text]
  • Annual Conference Journals Index to Memoirs
    Annual Conference Journals Index to Memoirs Surname First Name Spouse/Father Death/Funeral Date Journal Page Abbott Cleon Frederick Carol 10/6/1994 DC1995 308 Abbott William B. Olive 12/27/1969DC1970 957 Ackerman C.A. UB1946 31 Ackerman Mildred Earl 11/23/1976 DC1977 931 Adams Carl G. Emma Ruth Luzzader 10/2/1981DC1982 1567 Adams Carlos L. Emma Louise Cooper; Flora 8/20/1941 DC1942 550 Kempf Adams Emma Louise Cooper Carlos L. 11/12/1913DC1914 326 Adams Flora Kempf Carlos 8/15/1962DC1963 1135 Adams Robert 12/20/1931 EV1932 55 Ainge Clement Margaret Kershaw 1/30/1948 DC1948 182 Ainge Margaret Kershaw Clement 11/12/1934 DC1935 130 Ainsworth Miriam Ada H. William P 5/28/1954 DC1954 736 Ainsworth William P. Ada; Ethel May Carefoot 10/30/1965DC1966 1046 Alabaster Harriet Ann Bemish J. 10/17/1881 DC1882 37 Albery Paul Franklin Alice Nutting; Mary Barber 11/16/2006 DC2007 219 Willoughby Albig Hattie Loose Orville M. 8/26/1938 EV1939 52 Albig Orville M. Hattie Loose; Ella 2/8/1965 EUB1965 138 Albro Addis Mary Alice Scribner 10/15/1911 DC1912 44 Albro Mary Alice Scribner Addis 8/12/1905 DC1905 184 Allen Adelaide A. Andrews C.B. 11/3/1948 DC1949 448 Allen Alfred Louisa J. Hartwell 1/29/1903 DC1903 40 Allen Bertram E. Ida E. Hunt 5/28/1925DC1925 322 Allen Charlena Letts Eugene 10/9/1947 DC1948 186 Allen Charles Bronson Blanche 3/31/1953 DC1953 462 Allen Charles Thompson Elnora Root 10/12/1904DC1905 162 Allen Eugene Minnie M.
    [Show full text]
  • Captain Michael Pierce and the Fake Genealogy of Frederick Clifton Pierce
    1 Captain Michael Pierce and the Fake Genealogy of Frederick Clifton Pierce By Michael D Pierce [email protected] March 16, 2017 For some 140 years, many of the Captain Michael Pierce genealogies have contained serious errors that render these genealogies false in that they present a family history that did not exist. This paper addresses the following subjects: 1. Michael Pierce’s father was not Richard, James, or Azrikam. 2. His brothers were not William, John, Richard, or Robert. 3. Michael Pierce was related to Thomas Pierce of Charlestown, Massachusetts, but how they were related is unknown. Testing of Michael and Thomas’s descendants show shared DNA. 4. Michael Pierce did not have a middle name or initial. This one is not really the fault of FC Pierce except in perhaps an indirect way. 5. Deacon Mial Pierce was the son of Ephraim Pierce and Hannah Holbrook. He was not the son of Ephraim Pierce Jr. and Mary Low. 6. Judith Round’s maiden name was not Ellis. Many family genealogists of Michael Pierce (ca. 1615/20-1676) have used four Pierce genealogy books as their main source for their family research. Frederick Clifton Pierce wrote three of these books and contributed heavily to the fourth. There have been a few other books that have influenced family historians. For the most part these books have borrowed heavily from FC Pierce and contain the same errors, and occasionally have added new inaccuracies. Over a period of nine years FC Pierce evolved a false narrative on Captain Michael Pierce that, unfortunately, has been exacerbated by the continuous copying forward his flawed research into many Pierce genealogies.
    [Show full text]
  • Surnames - O-Q
    Index to Marion Child's Interviews SURNAMES - O-Q O'Brien, John……………………………… 445 O'Brien, Katherine………………………….. 14 O'Brien, Mary……………………………….. 19 O'Brien……………………………………….. 19..341..351..562 O'Conner, Mary………………………….. 563 O'Conner, Neil……………………………. 299 O'Conner……………………………………… 182..183..320..456..460..534..563..623 Odin, Joe……………………………………… 68..465 O'Donnell, Bill……………………………… 363 Oerther, George……………………………… 196 Oetgens, John Jacob………………….. 584 Oetgens, John……………………………. 474..586 Oetgens, Siegfried T…………………….. 584..585..586 Oetgens…………………………………… 474 Oetgens…………………………………… 584..585 Ogden…………………………………….. 276..547 O'Hara………………………………………… 150 Ohr (Orr), George…………………………… 109 Ohr, Tillie……………………………………. 51..53 Oliver, Nellie………………………………. 394 Oliver, Rev……………………………….. 580 Oliver………………………………………. 394..626 O'Meara, Rev………………………………… 189 O'Neil………………………………………. 391 O'Neill, Carolyn…………………………… 428..429 O'Neill, Henry…………………………….. 428..429 O'Neill, Mary………………………………. 428..503 O'Neill……………………………………… 503 Oocher, Danford Van……………………. 369 Opferman…………………………………. 397 O'Reilly, Marcella…………………………. 390 O'Reilly, Mary…………………………….. 390 O'Reilly, Rose…………………………….. 390 O'Reilly…………………………………….. 390 O'Riley, Father………………………………. 150 O'Riley…………………………………….. 315 Orvis, Harry, Doctor……………………….. 26 Orvis………………………………………….. 17..26..534 Osgood, Addison…………………………….. 125..127 Osgood, Laura……………………………….. 125..126..127..128 Osgood, Lester………………………………. 125 Osgood, Linus……………………………….. 125..126..127..172 Osgood, Martha "Aunt Martha"………….. 126..172 Osgood, Ralph……………………………….. 126 Osgood, Roxanna…………………………….
    [Show full text]
  • Report-Health Terminologies and Vocabularies Environmental Scan
    Health Terminologies and Vocabularies Environmental Scan Conducted for the National Committee on Vital and Health Statistics Subcommittee on Standards September 14, 2018 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Terminologies and Vocabularies Environmental Scan NCVHS Subcommittee on Standards This report was written by Susan L. Roy, MS, MLS, SNOMED CT Coordinator, and Vivian A. Auld, MLIS, Senior Specialist for Health Data Standards, both with the National Institutes of Health (NIH), National Library of Medicine, in collaboration with the NCVHS Standards Subcommittee: NCVHS Membership William W. Stead, MD, NCVHS Chair Nicholas L. Coussoule,* Subcommittee Co-chair Alexandra Goss,* Subcommittee Co-chair Bruce B. Cohen, PhD David A. Ross, ScD Debra Strickland, MS* Denise E. Love, BSN, MBA* Jacki Monson, JD Linda L. Kloss, MA, RHIA*, Terminology and Vocabulary Project Lead Llewellyn J. Cornelius, PhD Richard W. Landen, MPH, MBA* Robert L. Phillips, Jr., MD, MSPH Roland J. Thorpe, Jr., PhD Vickie M. Mays, PhD, MSPH *Member of the Subcommittee on Standards Rebecca Hines, MHS, NCVHS Executive Secretary/DFO Health Scientist National Center for Health Statistics, CDC, HHS Rashida Dorsey, PhD, MPH, NCVHS Executive Staff Director Director, Division of Data Policy Senior Advisor on Minority Health and Health Disparities Office of Science and Data Policy Office of the Assistant Secretary for Planning and Evaluation, HHS The National Committee on Vital and Health Statistics (NCVHS) serves as the advisory committee to the Secretary of Health and Human Services (HHS) on health data, statistics, privacy, national health information policy, and the Health Insurance Portability and Accountability Act (HIPAA) (42U.S.C.242k[k]).
    [Show full text]
  • Cayuga County Surname and Family Files in Town and Organization Collections
    Cayuga County Surname and Family Files In town and organization collections A B C D E F G 1 Surname Cayuga County Genoa Moravia Town of Town of Montezuma 2 x = family name on file Historian Hist. Assn. COLHS Sterling Victory Hist. Society 3 4 Moravia names also online @ www.colhs.org/p/surnames see 5 Montezuma names online @ www.montezumagen.com website 6 7 Abbe x 8 Abbott x x x x 9 Abbott-Nuitt x 10 Abraham(s) x 11 Abrams x x x 12 Acers x 13 Acker x 14 Ackerman x x 15 Ackerson x x x 16 Ackles x 17 Ackley x 18 Acre x 19 Adams x x x x 20 Adams-Crofoot x 21 Addy x 22 Adessa x 23 Adkins x 24 Adle x 25 Adolph x 26 Adriance x x 27 Adsitt x 28 Agree x 29 Aiken/Aikin x 30 Aikin x 31 Akin x 32 Akin (Aiken) x 33 Albertson x 34 Albie/Albee x 35 Albring x 36 Albro x 37 Alcorn x 38 Alcott/Alcox x 39 Alden x 40 Aldrich x x 41 Aldridge x 42 Alexander x x 43 Alfred x 44 Alger/Algur x 45 Algert x 46 Alifieri x 47 Alissandrello x 48 Allanson x 49 Allee x 50 Allen x x x x x 51 Alley x 52 Allis x 53 Almy x 54 Alnutt x x Cayuga County Surname and Family Files In town and organization collections A B C D E F G 1 Surname Cayuga County Genoa Moravia Town of Town of Montezuma 2 x = family name on file Historian Hist.
    [Show full text]
  • 2017 Purge List LAST NAME FIRST NAME MIDDLE NAME SUFFIX
    2017 Purge List LAST NAME FIRST NAME MIDDLE NAME SUFFIX AARON LINDA R AARON-BRASS LORENE K AARSETH CHEYENNE M ABALOS KEN JOHN ABBOTT JOELLE N ABBOTT JUNE P ABEITA RONALD L ABERCROMBIA LORETTA G ABERLE AMANDA KAY ABERNETHY MICHAEL ROBERT ABEYTA APRIL L ABEYTA ISAAC J ABEYTA JONATHAN D ABEYTA LITA M ABLEMAN MYRA K ABOULNASR ABDELRAHMAN MH ABRAHAM YOSEF WESLEY ABRIL MARIA S ABUSAED AMBER L ACEVEDO MARIA D ACEVEDO NICOLE YNES ACEVEDO-RODRIGUEZ RAMON ACEVES GUILLERMO M ACEVES LUIS CARLOS ACEVES MONICA ACHEN JAY B ACHILLES CYNTHIA ANN ACKER CAMILLE ACKER PATRICIA A ACOSTA ALFREDO ACOSTA AMANDA D ACOSTA CLAUDIA I ACOSTA CONCEPCION 2/23/2017 1 of 271 2017 Purge List ACOSTA CYNTHIA E ACOSTA GREG AARON ACOSTA JOSE J ACOSTA LINDA C ACOSTA MARIA D ACOSTA PRISCILLA ROSAS ACOSTA RAMON ACOSTA REBECCA ACOSTA STEPHANIE GUADALUPE ACOSTA VALERIE VALDEZ ACOSTA WHITNEY RENAE ACQUAH-FRANKLIN SHAWKEY E ACUNA ANTONIO ADAME ENRIQUE ADAME MARTHA I ADAMS ANTHONY J ADAMS BENJAMIN H ADAMS BENJAMIN S ADAMS BRADLEY W ADAMS BRIAN T ADAMS DEMETRICE NICOLE ADAMS DONNA R ADAMS JOHN O ADAMS LEE H ADAMS PONTUS JOEL ADAMS STEPHANIE JO ADAMS VALORI ELIZABETH ADAMSKI DONALD J ADDARI SANDRA ADEE LAUREN SUN ADKINS NICHOLA ANTIONETTE ADKINS OSCAR ALBERTO ADOLPHO BERENICE ADOLPHO QUINLINN K 2/23/2017 2 of 271 2017 Purge List AGBULOS ERIC PINILI AGBULOS TITUS PINILI AGNEW HENRY E AGUAYO RITA AGUILAR CRYSTAL ASHLEY AGUILAR DAVID AGUILAR AGUILAR MARIA LAURA AGUILAR MICHAEL R AGUILAR RAELENE D AGUILAR ROSANNE DENE AGUILAR RUBEN F AGUILERA ALEJANDRA D AGUILERA FAUSTINO H AGUILERA GABRIEL
    [Show full text]
  • STUDY PROTOCOL PASS Information Title a Multinational Active Safety Surveillance Study of Crizotinib In
    XALKORI (crizotinib) A8081038, A Multinational Active Safety Surveillance Study of Crizotinib in Europe Final Protocol, 02 April 2013 NON-INTERVENTIONAL (NI) STUDY PROTOCOL PASS Information Title A multinational active safety surveillance study of crizotinib in Europe Protocol number A8081038 Protocol version identifier Final (version 1.0) Date of last version of protocol 02 April 2013 EU Post Authorisation Study (PAS) Study has not yet registered register number Active substance L01XE16/Crizotinib Medicinal product XALKORI Product reference EU/1/12/793/001-004 Product number EMEA/H/C/002489 Marketing Authorisation Holder (MAH) Pfizer Limited Joint PASS No Research question and objectives The objective of this study is to evaluate the safety and effectiveness of crizotinib among lung cancer patients in the real world setting in Europe. Countries of study Denmark, Finland, Norway, Sweden, and the Netherlands Author Kui Huang, PhD, MPH Pfizer Inc 235 East 42nd Street New York, NY 10017 090177e1841a5124\Approved\Approved On: 03-Apr-2013 12:23 Pfizer Confidential Page 1 of 76 XALKORI (crizotinib) A8081038, A Multinational Active Safety Surveillance Study of Crizotinib in Europe Final Protocol, 02 April 2013 Marketing Authorisation Holder(s) Marketing Authorisation Holder(s) Pfizer Limited Ramsgate Road, Sandwich, Kent CT130NJ United Kingdom MAH contact person Kui Huang, PhD, MPH Pfizer Inc 235 East 42nd Street New York, NY 10017 This document contains confidential information belonging to Pfizer. Except as otherwise agreed to in writing, by accepting or reviewing this document, you agree to hold this information in confidence and not copy or disclose it to others (except where required by applicable law) or use it for unauthorized purposes.
    [Show full text]
  • Integra Balanced Fund
    Integra U.S. Value Growth Fund This Proxy report includes those votes cast by the following investment teams: • CIBC (formerly Atlantic Trust Company, NA) • Barrow, Hanley, Mewhinney & Strauss, Inc. Proxy Report Table of Contents CIBC Private Wealth Management Title Period Vote Summary Report 3rd Quarter (July 01, 2020 – Sept 30, 2020) Vote Summary Report 4th Quarter (Oct 01, 2020 – Dec 31, 2020) Vote Summary Report 1st Quarter (Jan 01, 2021 – March 31, 2021) Vote Summary Report 2nd Quarter (April 01, 2021 – June 30, 2021) Barrow, Hanley, Mewhinney & Strauss, Inc. Title Period Vote Summary Report 3rd Quarter (July 01, 2020 – Sept 30, 2020) Vote Summary Report 4th Quarter (Oct 01, 2020 – Dec 31, 2020) Vote Summary Report 1st Quarter (Jan 01, 2021 – March 31, 2021) Vote Summary Report 2nd Quarter (April 01, 2021 – June 30, 2021) *Please note that these proxy reports are provided to Integra directly from our Investment teams and are only available in English Board Statistics Report Parameters Used: Location(s): CIBC Private Wealth Management Account Group(s): All account groups Institution Account(s): All institution accounts Custodian Account(s): All custodian accounts Reporting Period: 7/1/20 to 6/30/21 Meeting Overview Voting Statistics Category Number Percentage Number of votable meetings 2,708 Number of meetings voted 2,702 99.78% 2,708 Number of meetings with at least 1 vote Against, Withhold or 987 36.45% Meetings Abstain 2,702 Ballot Overview 28,676 Ballots Votable Category Number Percentage 28,659 Voted Number of votable ballots
    [Show full text]
  • Annual Report 2011–12 3 Introduction
    ANNUAL REPORT 2011–12 3 Introduction 5 Metropolitan Opera Board of Directors 7 2011–12 Season Repertory & Events 14 2011–12 Artist Roster 15 The Financial Results 38 Patrons Introduction The Metropolitan Opera’s 2011–12 season was marked by an impressive string of artistic successes, while the company continued to address a challenging financial situation in ways that wouldn’t affect the high quality of productions. The company presented seven new stagings during the 2011–12 season, including the final two installments of a new Ring cycle, the Metropolitan Opera premiere of Donizetti’s Anna Bolena, and the world premiere of a new Baroque pastiche, The Enchanted Island, conceived by the Met. All seven new produc- tions, along with four revivals, were presented in movie theaters around the world as part of the Met’s Live in HD series, which has enabled the Met to assume a global leadership position as a provider of special cinema content. The Live in HD series continued to be a money-maker for the Met, earning $27.1 million. Combined earned revenue for the Met (Live in HD and box office) totaled $121.5 million. The 2011–12 season once again brought together the finest singers, conductors, directors, designers, choreog- raphers, and video artists in the world. Such extraordinary directors as Robert Lepage, Phelim McDermott, David McVicar, and Laurent Pelly returned to create new productions, with Michael Grandage and Des McAnuff making directorial debuts with the company. The culmination of Lepage’s new Met Ring cycle was the talk of the opera world, and the new Baroque pastiche The Enchanted Island, devised and written by Jeremy Sams, represented a remarkable new creative endeavor.
    [Show full text]
  • Download a PDF Version of the Guide to African American Manuscripts
    Guide to African American Manuscripts In the Collection of the Virginia Historical Society A [Abner, C?], letter, 1859. 1 p. Mss2Ab722a1. Written at Charleston, S.C., to E. Kingsland, this letter of 18 November 1859 describes a visit to the slave pens in Richmond. The traveler had stopped there on the way to Charleston from Washington, D.C. He describes in particular the treatment of young African American girls at the slave pen. Accomack County, commissioner of revenue, personal property tax book, ca. 1840. 42 pp. Mss4AC2753a1. Contains a list of residents’ taxable property, including slaves by age groups, horses, cattle, clocks, watches, carriages, buggies, and gigs. Free African Americans are listed separately, and notes about age and occupation sometimes accompany the names. Adams family papers, 1698–1792. 222 items. Mss1Ad198a. Microfilm reels C001 and C321. Primarily the papers of Thomas Adams (1730–1788), merchant of Richmond, Va., and London, Eng. Section 15 contains a letter dated 14 January 1768 from John Mercer to his son James. The writer wanted to send several slaves to James but was delayed because of poor weather conditions. Adams family papers, 1792–1862. 41 items. Mss1Ad198b. Concerns Adams and related Withers family members of the Petersburg area. Section 4 includes an account dated 23 February 1860 of John Thomas, a free African American, with Ursila Ruffin for boarding and nursing services in 1859. Also, contains an 1801 inventory and appraisal of the estate of Baldwin Pearce, including a listing of 14 male and female slaves. Albemarle Parish, Sussex County, register, 1721–1787. 1 vol.
    [Show full text]
  • Non-Interventional (Ni) Study Protocol Pass
    XALKORI (crizotinib) A8081038, A Multinational Active Safety Surveillance Study of Crizotinib in Europe Final Protocol Amendment 2, 19 Febuary 2015 NON-INTERVENTIONAL (NI) STUDY PROTOCOL PASS Information Title A multinational active safety surveillance study of crizotinib in Europe and the United States Protocol number A8081038 Protocol version identifier Final (version 1.2) Date of last version of protocol 19 Febuary 2015 EU Post Authorisation Study (PAS) ENCEPP/SDPP/8097 register number Active substance L01XE16/Crizotinib Medicinal product XALKORI Product reference EU/1/12/793/001-004 Product number EMEA/H/C/002489 Marketing Authorisation Holder (MAH) Pfizer Limited Joint PASS No Research question and objectives The objective of this study is to evaluate the safety and effectiveness of crizotinib among lung cancer patients in the real world setting in Europe and the United States. Countries of study Denmark, Finland, Sweden, the Netherlands and the United States Author Kui Huang, PhD, MPH Pfizer Inc 235 East 42nd Street New York, NY 10017 090177e18627024f\Approved\Approved On: 25-Feb-2015 14:49 Pfizer Confidential Page 1 of 63 XALKORI (crizotinib) A8081038, A Multinational Active Safety Surveillance Study of Crizotinib in Europe Final Protocol Amendment 2, 19 Febuary 2015 Marketing Authorisation Holder(s) Marketing Authorisation Holder(s) Pfizer Limited Ramsgate Road, Sandwich, Kent CT130NJ United Kingdom MAH contact person Kui Huang, PhD, MPH Pfizer Inc 235 East 42nd Street New York, NY 10017 This document contains confidential information belonging to Pfizer. Except as otherwise agreed to in writing, by accepting or reviewing this document, you agree to hold this information in confidence and not copy or disclose it to others (except where required by applicable law) or use it for unauthorized purposes.
    [Show full text]